The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide ... Ozempic for diabetes and obesity therapy Wegovy ...

The review follows a recent federally funded study that showed that people taking semaglutide, the medication in Ozempic and Wegovy, had a lower risk of suicidal thoughts than those taking other ...

WEIGHT loss jabs could banish blues as well as bellies, a study claims. People taking the injections showed “significantly ...

Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden ... There are no effective treatments for NAION.

The study published in the journal JAMA Ophthalmology focused on semaglutide, the GLP-1 agonist in Novo Nordisk’s diabetes therapy Ozempic ... of suicide, but no strong evidence for a link ...

Semaglutide is available as Wegovy and Ozempic injections, and also as Rybelsus tablets. The study's findings indicate a potential link ... and no difference was observed between both drugs”.